Open Label, Healthy Volunteers, ADME Study With Single Oral Administration of [14C] AZD5069

Summary

This is a phase I, open label, healthy volunteers, ADME study with single oral administration of \[14C\] AZD5069.

Timeline

Start

2011-05

Primary completion

2011-07

Completion

2011-07

Publications

• Cullberg M, Arfvidsson C, Larsson B, Malmgren A, Mitchell P, Wahlby Hamren U, Wray H. Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers. Drugs R D. 2018 Jun;18(2):149-159. doi: 10.1007/s40268-018-0236-x.

Drugs

Indications

No indication recorded.